Mestag Therapeutics Revenue and Competitors

London, UK

Location

$45M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Mestag Therapeutics's estimated annual revenue is currently $10.5M per year.(i)
  • Mestag Therapeutics's estimated revenue per employee is $155,000
  • Mestag Therapeutics's total funding is $45M.

Employee Data

  • Mestag Therapeutics has 68 Employees.(i)
  • Mestag Therapeutics grew their employee count by 13% last year.

Mestag Therapeutics's People

NameTitleEmail/Phone
1
Chief Medical Officer (cons)Reveal Email/Phone
2
Chief Scientific OfficerReveal Email/Phone
3
Chief Medical OfficerReveal Email/Phone
4
Chief Scientific OfficerReveal Email/Phone
5
SVP, Head DevelopmentReveal Email/Phone
6
Lead Assay Scientist and Biological Safety OfficerReveal Email/Phone
7
Director, Head BiologyReveal Email/Phone
8
Associate Director, Head PeopleReveal Email/Phone
9
Executive Assistant and Office ManagerReveal Email/Phone
10
Office ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M35-12%N/AN/A
#2
$16.3M1054%N/AN/A
#3
$107.2M49425%$292MN/A
#4
$2.6M83030%$631.7MN/A
#5
$18.1M117-8%$81MN/A
#6
$54.6M2820%$132.9MN/A
#7
$9.3M60-37%N/AN/A
#8
$21.2M13712%N/AN/A
#9
$408.2M164611%£994.6MN/A
#10
$963.5M621612%N/AN/A
Add Company

What Is Mestag Therapeutics?

Mestag Therapeutics is a fast-moving, stealth mode biotech, newly formed to explore emerging understanding of fibroblast subpopulations as targetable drivers of disease. Our goal is to bring transformative therapies to enriched patient populations with enduring unmet needs in inflammatory disease and oncology. Mestag Therapeutics' founders are world leaders in fibroblast biology and severe diseases. We are actively assembling a driven, motivated team to explore new therapeutic opportunities. Backed by SV Health Investors, a leading life sciences & healthcare investor with over $3 billion in capital commitments, Mestag has raised capital from the Impact Medicine Fund, which invests in precision medicine therapeutics in areas of high unmet need. We are hiring! Reach out to learn more about opportunities to join our team.

keywords:N/A

$45M

Total Funding

68

Number of Employees

$10.5M

Revenue (est)

13%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Mestag Therapeutics News

2022-04-06 - Nasdaq big hitter joins Mestag as non-exec director

Mestag Therapeutics, a breakthrough inflammatory disease and immuno-oncology company based in Cambridge, has appointed a life science...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.3M6824%N/A
#2
$8.9M68-8%$2M
#3
$7.5M6817%N/A
#4
$16.5M68-17%N/A
#5
$7.3M6810%N/A